172 related articles for article (PubMed ID: 30466785)
1. Valproic acid suppresses Warburg effect and tumor progression in neuroblastoma.
Fang E; Wang J; Hong M; Zheng L; Tong Q
Biochem Biophys Res Commun; 2019 Jan; 508(1):9-16. PubMed ID: 30466785
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic targeting of YY1/MZF1 axis by MZF1-uPEP inhibits aerobic glycolysis and neuroblastoma progression.
Fang E; Wang X; Wang J; Hu A; Song H; Yang F; Li D; Xiao W; Chen Y; Guo Y; Liu Y; Li H; Huang K; Zheng L; Tong Q
Theranostics; 2020; 10(4):1555-1571. PubMed ID: 32042322
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic targeting of circ-CUX1/EWSR1/MAZ axis inhibits glycolysis and neuroblastoma progression.
Li H; Yang F; Hu A; Wang X; Fang E; Chen Y; Li D; Song H; Wang J; Guo Y; Liu Y; Li H; Huang K; Zheng L; Tong Q
EMBO Mol Med; 2019 Dec; 11(12):e10835. PubMed ID: 31709724
[TBL] [Abstract][Full Text] [Related]
4. HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression.
Song H; Li D; Wang X; Fang E; Yang F; Hu A; Wang J; Guo Y; Liu Y; Li H; Chen Y; Huang K; Zheng L; Tong Q
J Hematol Oncol; 2020 Mar; 13(1):24. PubMed ID: 32216806
[TBL] [Abstract][Full Text] [Related]
5. Induction of differentiation and suppression of malignant phenotype of human neuroblastoma BE(2)-C cells by valproic acid: enhancement by combination with interferon-alpha.
Cinatl J; Kotchetkov R; Blaheta R; Driever PH; Vogel JU; Cinatl J
Int J Oncol; 2002 Jan; 20(1):97-106. PubMed ID: 11743648
[TBL] [Abstract][Full Text] [Related]
6. E2F1 promotes Warburg effect and cancer progression via upregulating ENO2 expression in Ewing sarcoma.
Jiang X; Chen Z; Zhu J; Han J; You G; Li Y; Liu T; Ye H
Mol Med Rep; 2022 Jul; 26(1):. PubMed ID: 35621141
[TBL] [Abstract][Full Text] [Related]
7. p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells.
Rocchi P; Tonelli R; Camerin C; Purgato S; Fronza R; Bianucci F; Guerra F; Pession A; Ferreri AM
Oncol Rep; 2005 Jun; 13(6):1139-44. PubMed ID: 15870934
[TBL] [Abstract][Full Text] [Related]
8. Thrombospondin-1 peptide ABT-510 combined with valproic acid is an effective antiangiogenesis strategy in neuroblastoma.
Yang Q; Tian Y; Liu S; Zeine R; Chlenski A; Salwen HR; Henkin J; Cohn SL
Cancer Res; 2007 Feb; 67(4):1716-24. PubMed ID: 17308113
[TBL] [Abstract][Full Text] [Related]
9. Impact of histone deacetylase inhibitor valproic acid on the anticancer effect of etoposide on neuroblastoma cells.
Groh T; Hrabeta J; Poljakova J; Eckschlager T; Stiborova M
Neuro Endocrinol Lett; 2012; 33 Suppl 3():16-24. PubMed ID: 23353839
[TBL] [Abstract][Full Text] [Related]
10. HOXA1 promotes aerobic glycolysis and cancer progression in cervical cancer.
Zhang Z; Peng J; Li B; Wang Z; Wang H; Wang Y; Hong L
Cell Signal; 2023 Sep; 109():110747. PubMed ID: 37286120
[TBL] [Abstract][Full Text] [Related]
11. E2F1 enhances glycolysis through suppressing Sirt6 transcription in cancer cells.
Wu M; Seto E; Zhang J
Oncotarget; 2015 May; 6(13):11252-63. PubMed ID: 25816777
[TBL] [Abstract][Full Text] [Related]
12. Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma.
Poljakova J; Hrebackova J; Dvorakova M; Moserova M; Eckschlager T; Hrabeta J; Göttlicherova M; Kopejtkova B; Frei E; Kizek R; Stiborova M
Neuro Endocrinol Lett; 2011; 32 Suppl 1():101-16. PubMed ID: 22167207
[TBL] [Abstract][Full Text] [Related]
13. Nifurtimox reduces N-Myc expression and aerobic glycolysis in neuroblastoma.
Cabanillas Stanchi KM; Bruchelt G; Handgretinger R; Holzer U
Cancer Biol Ther; 2015; 16(9):1353-63. PubMed ID: 26177922
[TBL] [Abstract][Full Text] [Related]
14. Sodium valproate potentiates staurosporine-induced apoptosis in neuroblastoma cells via Akt/survivin independently of HDAC inhibition.
Shah RD; Jagtap JC; Mruthyunjaya S; Shelke GV; Pujari R; Das G; Shastry P
J Cell Biochem; 2013 Apr; 114(4):854-63. PubMed ID: 23097134
[TBL] [Abstract][Full Text] [Related]
15. Histone demethylase JMJD1A promotes urinary bladder cancer progression by enhancing glycolysis through coactivation of hypoxia inducible factor 1α.
Wan W; Peng K; Li M; Qin L; Tong Z; Yan J; Shen B; Yu C
Oncogene; 2017 Jul; 36(27):3868-3877. PubMed ID: 28263974
[TBL] [Abstract][Full Text] [Related]
16. Effects of the histone deacetylase inhibitor valproic acid on Notch signalling in human neuroblastoma cells.
Stockhausen MT; Sjölund J; Manetopoulos C; Axelson H
Br J Cancer; 2005 Feb; 92(4):751-9. PubMed ID: 15685243
[TBL] [Abstract][Full Text] [Related]
17. Valproic acid Suppresses Breast Cancer Cell Growth Through Triggering Pyruvate Kinase M2 Isoform Mediated Warburg Effect.
Li Z; Yang L; Zhang S; Song J; Sun H; Shan C; Wang D; Liu S
Cell Transplant; 2021; 30():9636897211027524. PubMed ID: 34263655
[TBL] [Abstract][Full Text] [Related]
18. PTCSC3-mediated glycolysis suppresses thyroid cancer progression via interfering with PGK1 degradation.
Jiang B; Chen Y; Xia F; Li X
J Cell Mol Med; 2021 Sep; 25(17):8454-8463. PubMed ID: 34337858
[TBL] [Abstract][Full Text] [Related]
19. Sodium valproate inhibits in vivo growth of human neuroblastoma cells.
Cinatl J; Cinatl J; Driever PH; Kotchetkov R; Pouckova P; Kornhuber B; Schwabe D
Anticancer Drugs; 1997 Nov; 8(10):958-63. PubMed ID: 9436639
[TBL] [Abstract][Full Text] [Related]
20. Valproic Acid Increases CD133 Positive Cells that Show Low Sensitivity to Cytostatics in Neuroblastoma.
Khalil MA; Hraběta J; Groh T; Procházka P; Doktorová H; Eckschlager T
PLoS One; 2016; 11(9):e0162916. PubMed ID: 27627801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
